Commercialization of automated mobile device for accurate comprehensive refraction
Commercialization of automated mobile device for accurate comprehensive refraction
批准号:
10359070
负责人:
Gary Yiu-Kin Chu
金额:
$71.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-09-30 至 2025-02-28
关键词:
AcuteAdoptionAreaCapital FinancingCaringChildClinicClinicalClinical ResearchComputer softwareCountryCustomDevicesDocumentationEducationElectromagneticsEnsureEyeEyeglassesFeedbackFocus GroupsFreezingFund RaisingGoalsGroup InterviewsHealth PersonnelHealthcareImpairmentImprove AccessIncomeIndiaInstitutionMarket ResearchMarketingMeasurementOphthalmic examination and evaluationOutcomePatientsPerformancePersonsPhasePopulationPreparationProceduresProductivityProtocols documentationQuality ControlQuality of lifeRefractive ErrorsResearchResourcesSafetySalesSmall Business Innovation Research GrantStudy SubjectSystemTechnologyTestingTrainingValidationVisionWagesWorkbasecare providerscommercializationcostdesigndisabilityevaluation/testingexperiencehandheld mobile devicehealth care disparityhealth disparity populationshuman subjectimprovedinnovationlensminiaturizenew technologypoint of careportabilityprinted circuit boardprototyperesearch clinical testingscale uptoolvalidation studies
中文摘要
总结
该CRP SBIR应用程序的目标是将QuickSee Plus商业化,
在SBIR第二阶段工作期间开发。QuickSee Plus将成为眼科护理专业人员的独特工具,
在一个便携式包装中实现全面的验光(客观和主观)。它将提供
为眼科护理专业人员带来了巨大的价值,因为它提高了他们在诊所内的效率,
他们在诊所外的接触,从而更容易获得屈光眼科护理,
人口
英文摘要
Summary
The goal of this CRP SBIR application is to commercialize QuickSee Plus that was researched and
developed during SBIR Phase 2 work. QuickSee Plus, will be a unique tool for eye care professionals that
enables comprehensive refraction (objective and subjective) in a single, portable package. It will provide
tremendous value for eye care professionals as it improves their efficiency within the clinic and extends
their reach outside the clinic, thereby, greater accessibility to refractive eye care for health disparity
populations
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41598-022-07786-0
发表时间:
2022-03-08
期刊:
Scientific reports
影响因子:
4.6
作者:
[Gil A, Hernández CS, Nam AS, Varadaraj V, Durr NJ, Lim D, Dave SR, Lage E]
通讯作者:
Lage E
海外基金